期刊文献+

血管紧张素转换酶抑制剂的醛固酮逃逸现象 被引量:2

下载PDF
导出
出处 《兰州大学学报(医学版)》 CAS 2005年第2期100-102,105,共4页 Journal of Lanzhou University(Medical Sciences)
  • 相关文献

参考文献12

  • 1Takeda Y,Miyzmory,Yoneda T,et al.Production of aldosterone in isolated rat blood vessels[J].Hypertension,1995,25:170-173.
  • 2Robert V,Van Thiem N,Cheav S L,et al.Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension[J].Hypertension,1994,24:30-36.
  • 3Hatakeyma H,Miyamortl,Fujita T,et al.Vascular aldosterone.Biosynthesis and a link to argiotensin II jnduced hypertrophy of vascular smooth muscle cells[J].J Biol Chem,1994,269:24316-24320.
  • 4Rizzoni D,Muiesan M L,Perteri E,et al.Relation between cardiac and vascular structure in patients with primary and secondary hypertension[J].J Am Cardiol,1998,32:985-992.
  • 5Gomez,Sanchez C E.Aldosterone biosynthesis in the rat brain[J].Endocrinology,1997,138:3369-3373.
  • 6Gomez Sanchez E P,Zhou M,Gomez C E.Mineraldocorticoid,salt and high blood pressure[J].Steroids,1996,6:184-188.
  • 7Ramires F J,Mansur A,Coelho O,et al.Effect of Spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or ischemic cardiomy[J].Am J Cardiol,2000,85:1207-1211.
  • 8Korkmaz M E,Muderriaogtu H,Ulucam M.et al.Effectof Spironolactone on heart rate variability and left ventricular systolic function in severe ischemic heart failure[J].Am J Cardiol,2000,86:649-653.
  • 9Cicoira M,Aanolla L,Rossi A,et al.Failure of aldosterone Suppression despite angiontensin-cenverting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype[J].J Am Coll Cardiol,2001,37:1808-1812.
  • 10Takeda Y,Yoneda T,Demura M,et al.Effects of highsodium intake on cardiovascular aldosterone synthesis in seroke-prone spontaneously hypertensive rats[J].J Hypertens,2001,19:635-639.

同被引文献24

  • 1付红莉,房振英.醛固酮逃逸和心血管疾病[J].心血管病学进展,2004,25(6):461-463. 被引量:9
  • 2心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):5-16. 被引量:552
  • 3中华医学会心血管病学分会,中华心血管病杂志编辑委员会.慢性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2014.42(2):1-25.
  • 4Biteker M,Kayatas K.Duman D,et al.Peripartum cardiomyopathy:current state of knowledge,new developments and future directions[J].Curr Cardiol Rev,2014,10(4):317-326.
  • 5Fett JD.Understanding peripartum cardiomyopathy[J].2008,Int J Cardiol,2008,130(l):l-2.
  • 6Sheppard R,Rajagopalan N,Safirstein J,et al.An update on treatments and outcomes in peripartum cardiomyopathy[J].Future Cardiol,2014,10(3):435-447.
  • 7Abboud J,Murad Y,Chen-Scarabelli C,et al.Peripartum cardiomyopathy:a comprehensive review[J].Int J Cardiol,2007,118(3):295-303.
  • 8Pillarisetti J,Kondur A,Alani A,et al.Peripartum cardiomyopathy[J].J Am Coll Cardiol,2014,63(25):2831-2839.
  • 9Sliwa K,Forster O,Tibazarwa K,et al.Long-term outcome of peripartum cardiomyopathy in a population with high seropositivity for human immunodeficiency virus[J].Int J Cardiol,2011,147(2):202-208.
  • 10Huang GY,Zhang LY,Long-Le MA,et al.Clinical characteristics and risk factors for peripartum cardiomyopathy[J].Afr Health Sci,2012,12(1):26-31.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部